KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

LifeMD (LFMD) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for LifeMD (LFMD) over the last 14 years, with Q3 2025 value amounting to 3.27%.

  • LifeMD's EBITDA Margin rose 42300.0% to 3.27% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.15%, marking a year-over-year increase of 75200.0%. This contributed to the annual value of 8.75% for FY2024, which is 7500.0% up from last year.
  • Per LifeMD's latest filing, its EBITDA Margin stood at 3.27% for Q3 2025, which was up 42300.0% from 0.72% recorded in Q2 2025.
  • Over the past 5 years, LifeMD's EBITDA Margin peaked at 1.52% during Q1 2025, and registered a low of 72.27% during Q2 2021.
  • In the last 5 years, LifeMD's EBITDA Margin had a median value of 13.62% in 2023 and averaged 24.56%.
  • Data for LifeMD's EBITDA Margin shows a peak YoY increase of 2008900bps (in 2021) and a maximum YoY decrease of -368700bps (in 2021) over the last 5 years.
  • Over the past 5 years, LifeMD's EBITDA Margin (Quarter) stood at 49.84% in 2021, then grew by 26bps to 36.88% in 2022, then skyrocketed by 87bps to 4.84% in 2023, then plummeted by -33bps to 6.46% in 2024, then skyrocketed by 49bps to 3.27% in 2025.
  • Its last three reported values are 3.27% in Q3 2025, 0.72% for Q2 2025, and 1.52% during Q1 2025.